taurine has been researched along with Renal Insufficiency, Chronic in 5 studies
Renal Insufficiency, Chronic: Conditions in which the KIDNEYS perform below the normal level for more than three months. Chronic kidney insufficiency is classified by five stages according to the decline in GLOMERULAR FILTRATION RATE and the degree of kidney damage (as measured by the level of PROTEINURIA). The most severe form is the end-stage renal disease (CHRONIC KIDNEY FAILURE). (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002)
Excerpt | Relevance | Reference |
---|---|---|
"Amelioration of both oxidative and inflammation status after cholesterol lowering treatment in CKD might be mediated by restoration of antioxidant taurine concentrations during therapy (from 51." | 5.20 | Impact of cholesterol lowering treatment on plasma kynurenine and tryptophan concentrations in chronic kidney disease: relationship with oxidative stress improvement. ( Carru, C; Mangoni, AA; Sanna, M; Satta, AE; Sotgia, S; Zinellu, A, 2015) |
" L-glutamine supplementation failed to rectify taurine biosynthesis or CSAD protein expression, but worsened CKD (proteinuria in NxT 12." | 4.02 | Hepatic cysteine sulphinic acid decarboxylase depletion and defective taurine metabolism in a rat partial nephrectomy model of chronic kidney disease. ( Abbasian, N; Bevington, A; Brown, J; Bursnall, D; Ghaderi-Najafabadi, M; Pawluczyk, I; Seymour, AM; Watson, E; Yu Si, L, 2021) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 2 (40.00) | 2.80 |
Authors | Studies |
---|---|
Sengupta, P | 1 |
Biswas, S | 1 |
Roy, T | 1 |
Abbasian, N | 1 |
Ghaderi-Najafabadi, M | 1 |
Watson, E | 1 |
Brown, J | 1 |
Yu Si, L | 1 |
Bursnall, D | 1 |
Pawluczyk, I | 1 |
Seymour, AM | 1 |
Bevington, A | 1 |
Chen, DQ | 1 |
Cao, G | 1 |
Chen, H | 1 |
Argyopoulos, CP | 1 |
Yu, H | 1 |
Su, W | 1 |
Chen, L | 1 |
Samuels, DC | 1 |
Zhuang, S | 1 |
Bayliss, GP | 1 |
Zhao, S | 1 |
Yu, XY | 1 |
Vaziri, ND | 1 |
Wang, M | 1 |
Liu, D | 1 |
Mao, JR | 1 |
Ma, SX | 1 |
Zhao, J | 1 |
Zhang, Y | 1 |
Shang, YQ | 1 |
Kang, H | 1 |
Ye, F | 1 |
Cheng, XH | 1 |
Li, XR | 1 |
Zhang, L | 1 |
Meng, MX | 1 |
Guo, Y | 1 |
Zhao, YY | 1 |
Zinellu, A | 1 |
Sotgia, S | 1 |
Mangoni, AA | 1 |
Sanna, M | 1 |
Satta, AE | 1 |
Carru, C | 1 |
Davies, M | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Effect of Dapagliflozin on Metabolomics and Cardiac Mechanics in Chronic Kidney Disease[NCT05719714] | Phase 1/Phase 2 | 60 participants (Anticipated) | Interventional | 2023-11-01 | Recruiting | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 review available for taurine and Renal Insufficiency, Chronic
Article | Year |
---|---|
Veterinary clinical nutrition: success stories: an overview.
Topics: Animal Nutritional Physiological Phenomena; Animals; Calculi; Cardiomyopathies; Cardiomyopathy, Dila | 2016 |
2 trials available for taurine and Renal Insufficiency, Chronic
Article | Year |
---|---|
Comparative Study to Evaluate the Effect of Low-Protein Diet Supplementation with Taurine and N-Acetylcysteine, N-Acetylcysteine and Pyridoxamine Dihydrochloride in Preventing the Progression of Chronic Renal Failure in Patients with Non-Diabetic Kidney D
Topics: Acetylcysteine; Adult; Aged; Diet, Protein-Restricted; Dietary Supplements; Disease Progression; Fem | 2022 |
Impact of cholesterol lowering treatment on plasma kynurenine and tryptophan concentrations in chronic kidney disease: relationship with oxidative stress improvement.
Topics: Aged; Allantoin; Anticholesteremic Agents; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Dose-Res | 2015 |
2 other studies available for taurine and Renal Insufficiency, Chronic
Article | Year |
---|---|
Hepatic cysteine sulphinic acid decarboxylase depletion and defective taurine metabolism in a rat partial nephrectomy model of chronic kidney disease.
Topics: Animals; Carboxy-Lyases; Cysteine Dioxygenase; Dietary Supplements; Disease Models, Animal; Glutamin | 2021 |
Identification of serum metabolites associating with chronic kidney disease progression and anti-fibrotic effect of 5-methoxytryptophan.
Topics: Acetylcarnitine; Animals; Canavanine; Carnitine; Case-Control Studies; Disease Models, Animal; Disea | 2019 |